Prior Medications and the Cardiovascular Benefits From Combination Angiotensin‐Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High‐Risk Hypertensive Patients

BACKGROUND: The ACCOMPLISH (Avoiding Cardiovascular Events Through Combination Therapy in Patients Living with Systolic Hypertension) trial demonstrated that combination therapy using amlodipine, rather than hydrochlorothiazide, in conjunction with benazepril provided greater cardiovascular risk red...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Am Heart Assoc
Main Authors: Brook, Robert D., Kaciroti, Niko, Bakris, George, Dahlöf, Björn, Pitt, Bertram, Velazquez, Eric, Weber, Michael, Zappe, Dion H., Hau, Tsushung, Jamerson, Kenneth A.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5778960/
https://ncbi.nlm.nih.gov/pubmed/29301757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006940
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki